Latest Insider Transactions at Gemini Therapeutics, Inc. (GMTX)
This section provides a real-time view of insider transactions for Gemini Therapeutics, Inc. (GMTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Gemini Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Gemini Therapeutics, Inc. 's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 18
2025
|
Rahul Khara Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,161
-3.0%
|
$62,694
$54.58 P/Share
|
|
Feb 18
2025
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,137
-4.32%
|
$169,398
$54.58 P/Share
|
|
Feb 18
2025
|
Jean M. Franchi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,136
-4.32%
|
$169,344
$54.58 P/Share
|
|
Feb 18
2025
|
Jonathan Yen Wen Yu Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,610
-3.82%
|
$86,940
$54.58 P/Share
|
|
Feb 18
2025
|
William Jacob Savage Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,638
-2.34%
|
$88,452
$54.58 P/Share
|
|
Feb 18
2025
|
John D Quisel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,574
-3.48%
|
$300,996
$54.58 P/Share
|
|
Feb 10
2025
|
Pamela Stephenson Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,000
+33.13%
|
-
|
|
Feb 10
2025
|
Jonathan Yen Wen Yu Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+36.27%
|
-
|
|
Feb 10
2025
|
Rahul Khara Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+38.69%
|
-
|
|
Feb 10
2025
|
John D Quisel Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
78,337
+32.81%
|
-
|
|
Feb 10
2025
|
Jean M. Franchi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,000
+33.13%
|
-
|
|
Feb 10
2025
|
William Jacob Savage Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+25.5%
|
-
|
|
Feb 03
2025
|
William Jacob Savage Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,731
+5.9%
|
$11,462
$2.65 P/Share
|
|
Feb 03
2025
|
Rahul Khara Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
7,500
-18.92%
|
$412,500
$55.71 P/Share
|
|
Feb 03
2025
|
Rahul Khara Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+25.83%
|
$105,000
$14.69 P/Share
|
|
Jan 02
2025
|
Rahul Khara Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
7,500
-13.19%
|
$472,500
$63.01 P/Share
|
|
Jan 02
2025
|
Rahul Khara Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+25.83%
|
$105,000
$14.69 P/Share
|
|
Dec 31
2024
|
John D Quisel Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+10.86%
|
$10,000
$1.01 P/Share
|
|
Dec 30
2024
|
John D Quisel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
13,012
-7.81%
|
$806,744
$62.14 P/Share
|
|
Dec 30
2024
|
John D Quisel Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,012
+13.27%
|
$117,108
$9.86 P/Share
|
|
Dec 23
2024
|
John D Quisel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
19,820
-7.67%
|
$1,248,660
$63.1 P/Share
|
|
Dec 23
2024
|
John D Quisel Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,820
+17.74%
|
$39,640
$2.65 P/Share
|
|
Dec 16
2024
|
John D Quisel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
12,791
-3.94%
|
$831,415
$65.95 P/Share
|
|
Dec 16
2024
|
John D Quisel Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,791
+13.1%
|
$12,791
$1.01 P/Share
|
|
Dec 02
2024
|
William Richard White |
SELL
Open market or private sale
|
Direct |
1,957
-64.06%
|
$125,248
$64.47 P/Share
|
|
Dec 02
2024
|
William Richard White |
BUY
Exercise of conversion of derivative security
|
Direct |
1,957
+29.66%
|
$11,742
$6.26 P/Share
|
|
Nov 25
2024
|
William Jacob Savage Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
14,183
-9.41%
|
$921,895
$65.93 P/Share
|
|
Nov 25
2024
|
William Jacob Savage Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,183
+12.19%
|
$156,013
$11.68 P/Share
|
|
Nov 15
2024
|
William Jacob Savage Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,158
-6.33%
|
$549,480
$60.27 P/Share
|
|
Nov 15
2024
|
William Jacob Savage Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,158
+15.6%
|
$82,422
$9.86 P/Share
|
|
Nov 04
2024
|
William Richard White |
SELL
Open market or private sale
|
Direct |
7,136
-62.54%
|
$413,888
$58.26 P/Share
|
|
Nov 04
2024
|
William Richard White |
BUY
Exercise of conversion of derivative security
|
Direct |
7,136
+50.0%
|
$321,120
$45.69 P/Share
|
|
Nov 01
2024
|
William Richard White |
SELL
Open market or private sale
|
Direct |
201
-67.91%
|
$9,246
$46.22 P/Share
|
|
Nov 01
2024
|
William Richard White |
BUY
Exercise of conversion of derivative security
|
Direct |
201
+50.0%
|
$1,809
$9.86 P/Share
|
|
Oct 01
2024
|
William Richard White |
SELL
Open market or private sale
|
Direct |
201
-44.59%
|
$10,050
$50.88 P/Share
|
|
Oct 01
2024
|
William Richard White |
BUY
Exercise of conversion of derivative security
|
Direct |
201
+50.0%
|
$1,809
$9.86 P/Share
|
|
Sep 16
2024
|
William Jacob Savage Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,500
-3.58%
|
$70,500
$47.41 P/Share
|
|
Sep 03
2024
|
William Richard White |
SELL
Open market or private sale
|
Direct |
1,957
-86.98%
|
$97,850
$50.89 P/Share
|
|
Sep 03
2024
|
William Richard White |
BUY
Exercise of conversion of derivative security
|
Direct |
1,957
+48.65%
|
$11,742
$6.26 P/Share
|
|
Sep 03
2024
|
William Jacob Savage Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,500
-3.46%
|
$75,000
$50.59 P/Share
|
|
Aug 01
2024
|
William Richard White |
SELL
Open market or private sale
|
Direct |
201
-85.82%
|
$8,643
$43.6 P/Share
|
|
Aug 01
2024
|
William Richard White |
BUY
Exercise of conversion of derivative security
|
Direct |
201
+50.0%
|
$1,809
$9.86 P/Share
|
|
Jul 08
2024
|
John D Quisel Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+4.0%
|
$3,000
$1.01 P/Share
|
|
Jul 01
2024
|
William Richard White |
SELL
Open market or private sale
|
Direct |
201
-56.17%
|
$9,045
$45.81 P/Share
|
|
Jul 01
2024
|
William Richard White |
BUY
Exercise of conversion of derivative security
|
Direct |
201
+50.0%
|
$1,809
$9.86 P/Share
|
|
Jun 17
2024
|
Kevin Bitterman |
BUY
Open market or private purchase
|
Indirect |
222,223
+34.57%
|
$8,000,028
$36.0 P/Share
|
|
Jun 17
2024
|
Mona Ashiya Director |
BUY
Open market or private purchase
|
Indirect |
83,334
+4.46%
|
$3,000,024
$36.0 P/Share
|
|
Jun 17
2024
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
83,334
+4.46%
|
$3,000,024
$36.0 P/Share
|
|
Jun 17
2024
|
Ai Dmi LLC |
BUY
Grant, award, or other acquisition
|
Direct |
416,667
+10.48%
|
$15,000,012
$36.0 P/Share
|
|
Jun 03
2024
|
William Richard White |
SELL
Open market or private sale
|
Direct |
1,957
-66.78%
|
$68,495
$35.99 P/Share
|